You are here: Industry Insights > HRT

News List

HRT Could Raise Odds for Asthma drugs
August 04, 2021
Millions of women who take hormone replacement therapy (HRT) to ease their transition through menopause may be unknowingly upping their risk for asthma.
Could Menopausal Hormone Therapy Reduce Women's Odds for Dementia? drugs
July 21, 2021
Women on hormone replacement therapy (HRT) for menopause go on to have a 58% lower risk of Alzheimer's disease and other neurodegenerative conditions, a new study finds.
EMA recommends updating safety information for HRT and leuprorelin europeanpharmaceuticalreview
May 19, 2020
The EMA has suggested that the safety information be updated for HRT, to reflect a higher risk of breast cancer and recommends new measures for the handling of leuprorelin depot medicines.
New transdermal HRT spray rolled out in the UK pharmatimes
April 16, 2020
Gedeon Richter has launched its new hormone replace therapy (HRT) Lenzetto (estradiol spray) in the UK, offering post-menopausal women an alternative treatment option for symptoms of oestrogen deficiency.
HRT Could Benefit Younger Women After Hysterectomy drugs
September 10, 2019
Estrogen therapy may help younger women live longer after having their uterus and ovaries surgically removed, new research reports.
Type and Timing of Menopausal HRT Affect Risk of Breast Cancer drugs
September 02, 2019
Use of menopausal hormone therapy (MHT) is associated with increased incidence of breast cancer, according to a study published online in The Lancet.
HRT shortage in UK expected to continue until next year europeanpharmaceuticalreview
August 29, 2019
Around half of HRT products have been reported as out of stock in UK pharmacies due to supply issues in China, leading to a shortage.
Bioengineered ovaries found to be more effective than HRT europeanpharmaceuticalreview
May 05, 2019
New research in rats suggests the possibility of bioengineering artificial ovaries in the lab to provide a safer, more natural hormone replacement therapy for women…
FDA approves combination HRT to treat hot flushes associated with menopause October 30, 2018
The US Food and Drug Administration (FDA) has approved female-focused pharmaceutical company TherapeuticsMD’s TX-001HR (Bijuva) for the treatment of vasomotor symptoms, such as hot flushes, due to menopause.